---

$2.91

-0.2100 ( -6.73% ) 28.5K

CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2023-11-22	Sale	-32000.00	TANNER JOHN WILLIAM
2023-11-09	Sale	-10000.00	Gregoire Sylvie
2023-11-09	Sale	-12500.00	ALAM JOHN J
2023-09-15	Sale	-6450.00	Poulton Jeffrey V.
2023-09-15	Sale	-6450.00	Gregoire Sylvie
2023-09-15	Sale	-6450.00	ZAVRL FRANK
2023-09-15	Sale	-35500.00	ALAM JOHN J
2023-09-15	Sale	-16000.00	TANNER JOHN WILLIAM
2023-09-15	Sale	-16000.00	Cobuzzi Robert Joseph Jr.
2023-09-15	Sale	-6450.00	DAVIDSON JILL